Data as of Mar 14
| +14.29 / +3.19%|
The 7 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 450.00, with a high estimate of 600.00 and a low estimate of 87.20. The median estimate represents a -2.60% decrease from the last price of 462.02.
The current consensus among 7 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.